122
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Simvastatin Plus Nitric Oxide Synthase Inhibition Modulates Remote Organ Damage Following Skeletal Muscle Ischemia-Reperfusion Injury

, BSc(Hons), PhD, , BMedSci, BMBS, , MBChB, FRCSI, , BSc(Hons), PhD, AStat & , MBBS, MS, FRACS
Pages 119-126 | Published online: 09 Jul 2009

REFERENCES

  • Norwood M G, Bown M J, Sayers R D. Ischaemia-reperfusion injury and regional inflammatory responses in abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2004; 28: 234–245
  • Adembri C, Kastamoniti E, Bertolozzi L, et al. Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery. Crit Care Med 2004; 32: 1170–1177
  • Groeneveld A B, Raijmakers P G, Rauwerda J A, et al. The inflammatory response to vascular surgery-associated ischaemia and reperfusion in man: effect on postoperative pulmonary function. Eur J Vasc Endovasc Surg 1997; 14: 351–359
  • Tallgren M, Niemi T, Poyhia R, et al. Acute renal injury and dysfunction following elective abdominal aortic surgery. Eur J Vasc Endovasc Surg 2007; 33: 550–555
  • Laws P E, Spark J I, Cowled P A, et al. The role of statins in vascular disease. Eur J Vasc Endovasc Surg 2004; 27: 6–16
  • Cowled P A, Khanna A, Laws P E, et al. Statins inhibit neutrophil infiltration in skeletal muscle reperfusion injury. J Surg Res 2007; 141: 267–276
  • Dillon J P, Laing A J, Chandler J R, et al. Pravastatin attenuates tourniquet-induced skeletal muscle ischemia reperfusion injury. Acta Orthop 2006; 77: 27–32
  • Emanueli C, Monopoli A, Kraenkel N, et al. Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb Ischaemia in type-1 diabetic mice. Br J Pharmacol 2007; 150: 873–882
  • Cowled P A, Leonardos L, Millard S H, et al. Apoptotic cell death makes a minor contribution to reperfusion injury in skeletal muscle in the rat. Eur J Vasc Endovasc Surg 2001; 21: 28–34
  • Roach D M, Fitridge R A, Laws P E, et al. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg 2002; 23: 260–269
  • Lindsey M, Wedin K, Brown M D, Keller C, Evans A J, Smolen J. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 2001; 103: 2181–2187
  • Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 1998; 101: 2711–2719
  • Wagner A H, Schwabe O, Hecker M. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ. Br J Pharmacol 2002; 136: 143–149
  • Tanaka J, Ishida Y, Ohshima T, et al. The gene expression of cytokines and chemokines induced by tourniquet shock in mice. Leg Med (Tokyo) 2003; 5: 146–155
  • Tiefenbacher C P, Kapitza J, Dietz V, et al. Reduction of myocardial infarct size by fluvastatin. Am J Physiol Heart Circ Physiol 2003; 285: H59–64
  • Trinkl A, Vosko M R, Wunderlich N, et al. Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion. Eur J Neurosci 2006; 24: 520–526
  • Sun X F, Wang L L, Wang J K, et al. Effects of simvastatin on lung injury induced by ischaemia-reperfusion of the hind limbs in rats. J Int Med Res 2007; 35: 523–533
  • Joyce M, Kelly C J, Chen G, et al. Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase. Eur J Vasc Endovasc Surg 2001; 21: 295–300
  • Khanna A, Cowled P A, Fitridge R A. Nitric oxide and skeletal muscle reperfusion injury: current controversies (research review). J Surg Res 2005; 128: 98–107
  • Wang W Z, Fang X H, Stephenson L L, et al. Microcirculatory effects of melatonin in rat skeletal muscle after prolonged ischemia. J Pineal Res 2005; 39: 57–65
  • Zimiani K, Guarnier F A, Miranda H C, et al. Nitric oxide mediated oxidative stress injury in rat skeletal muscle subjected to ischemia/reperfusion as evaluated by chemiluminescence. Nitric Oxide 2005; 13: 196–203
  • Di Napoli P, Taccardi A A, Grilli A, et al. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. Cardiovasc Res 2005; 66: 462–471
  • Madonna R, Di Napoli P, Massaro M, et al. Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts. J Biol Chem 2005; 280: 13503–13511
  • McCall T B, Feelisch M, Palmer R M, et al. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol 1991; 102: 234–238
  • Rees D D, Palmer R M, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746–752
  • Harkin D W, Rubin B B, Romaschin A, et al. Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm. J Surg Res 2004; 120: 230–241
  • Qi W N, Chen L E, Zhang L, et al. Reperfusion injury in skeletal muscle is reduced in inducible nitric oxide synthase knockout mice. J Appl Physiol 2004; 97: 1323–1328
  • Rivera-Chavez F A, Toledo-Pereyra L H, Dean R E, et al. Exogenous and endogenous nitric oxide but not iNOS inhibition improves function and survival of ischemically injured livers. J Invest Surg 2001; 14: 267–273
  • Cuzzocrea S, Misko T P, Costantino G, et al. Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. Faseb J 2000; 14: 1061–1072
  • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22
  • Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 2007; 45: 645–654, discussion 653–644

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.